-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, E11KnkSbsWDlVlV1IiIP/GO0ijfAU7GC8e4HfnL+vNM7wLXoH8yBRJGg/AyJTsdC wSts+VXk9Zp7TlJTRTgQ/A== 0000927016-02-006059.txt : 20021226 0000927016-02-006059.hdr.sgml : 20021225 20021226120346 ACCESSION NUMBER: 0000927016-02-006059 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20021226 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: TABIN JULIUS CENTRAL INDEX KEY: 0001086159 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 162 PARK AVENUE CITY: GLENCOA STATE: IL ZIP: 60022 MAIL ADDRESS: STREET 1: 162 PARK AVENUE CITY: GLENCOA STATE: IL ZIP: 60022 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ CENTRAL INDEX KEY: 0000819689 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 720925679 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-40548 FILM NUMBER: 02868777 BUSINESS ADDRESS: STREET 1: 25 SAWYER PASSWAY STREET 2: 25 SAWYER PASSWAY CITY: FITCHBURG STATE: MA ZIP: 01420 BUSINESS PHONE: 978-345-5000 MAIL ADDRESS: STREET 1: 25 SAWYER PASSWAY STREET 2: 25 SAWYER PASSWAY CITY: FITCHBURG STATE: MA ZIP: 01420 SC 13D 1 dsc13d.txt SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 ARRHYTHMIA RESEARCH TECHNOLOGY, INC. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, Par Value $.01 - -------------------------------------------------------------------------------- (Title of Class of Securities) 042698308 - -------------------------------------------------------------------------------- (CUSIP Number) Mr. Julius Tabin Fitch, Even, Tabin & Flannery 120 South LaSalle Street, Suite 1600 Chicago, Illinois 60603 (312) 372-7842 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) November 14, 2002 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box [_]. Check the following box if a fee is being paid with the statement [_]. (A fee is not required only if the reporting person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7.) NOTE: Six copies of this statement, including one original and all exhibits, should be filed with the Commission. See Rule 13-d1(a) for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP NO. 042698308 SCHEDULE 13D PAGE 2 OF 3 PAGES - -------------------------------------------------------------------------------- 1. Name of Reporting Persons I.R.S. Identification Nos. of above persons (entities only). Julius Tabin - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) [_] (b) [_] - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Source of Funds (See Instructions) PF - -------------------------------------------------------------------------------- 5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) [_] - -------------------------------------------------------------------------------- 6. Citizenship or Place of Organization U.S. - -------------------------------------------------------------------------------- 7. Sole Voting Power 138,824 Shares Common Stock, $.01 Par Value Number of ------------------------------------------------------------- Shares 8. Shared Voting Power Beneficially by Owned by ------------------------------------------------------------- Each 9. Sole Dispositive Power Reporting 138,824 Shares Common Stock, $.01 Par Value Person With ------------------------------------------------------------- 10. Shared Dispositive Power - -------------------------------------------------------------------------------- 11. Aggregate Amount Beneficially Owned by Each Reporting Person 138,824 Shares Common Stock, $.01 Par Value - -------------------------------------------------------------------------------- 12. Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares* [_] - -------------------------------------------------------------------------------- 13. Percent of Class Represented by Amount in Row (11) 5.1% - -------------------------------------------------------------------------------- 14. Type of Reporting Person (See Instructions) IN - -------------------------------------------------------------------------------- *See Instructions before filling out. CUSIP NO. 042698308 SCHEDULE 13D PAGE 3 OF 3 PAGES - -------------------------------------------------------------------------------- Item 1. Security and Issuer This statement relates to the $.01 Par Value Common Stock ("Common Stock") of Arrhythmia Research Technology, Inc. ("ART"), the principal executive offices of which are located at 25 Sawyer Passway, Fitchburg, Massachusetts 01420 Item 2. Identity and Background (a) Julius Tabin (b) Mr. Tabin's business address is Fitch, Even, Tabin & Flannery, 120 South LaSalle Street, Suite 1600, Chicago, IL 60603 (c) Mr. Tabin's principal occupation is as a partner in the previous listed law firm. (d) Mr. Tabin has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) during the last five years. (e) Mr. Tabin has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of any such proceeding was or is subject to a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws during the last five years. (f) Mr. Tabin is a citizen of the United States. Item 3. Source and Amount of Funds or Other Consideration The Common Stock of ART acquired by Mr. Tabin has been purchased for an aggregate cash consideration of $158,236.14, utilizing personal funds. Item 4. Purpose of Transaction Mr. Tabin has purchased the Common Stock of ART for investment purposes. Item 5. Interest in Securities of the Issuer (a) The aggregate number of shares of Common Stock of ART beneficially owned by Mr. Tabin and the percentage which those shares are of the outstanding Common Stock of ART are as follows: Julius Tabin 138,824 shares 5.1% (b) Mr. Tabin has the sole power to vote and the sole power to dispose or direct the disposition of all of the shares of Common Stock listed in subpart (a) of this Item. (c) The following transactions in the Common Stock of ART were completed to attain 5% ownership:
Amount of Price / Where and Amount of Price / Where and How ---------- ------- --------- --------- ------- ------------- Date Securities Share How Effected Date Securities Share Effected ---- ---------- ----- ------------ ---- ---------- ----- -------- 11/06/87 15,000* Initial 10/08/98 3,200 $1.0625 Open Market 03/08/88 3:2 Rev Stk Split 10/13/98 8,000 $1.0625 Open Market 07/21/88 4,809* 10/15/98 200 $1.0625 Open Market 05/23/89 566* 10/23/98 1,700 $1.0625 Open Market 09/06/89 2:1 Rev Stk Split 10/27/98 6,700 $1.0625 Open Market 08/06/90 2:1 Rev Stk Split 10/28/98 200 $1.0625 03/01/95 8,103 $1.88 Open Market 04/23/99 8,333 $1.0000 Comp.for Dir.Svcs 08/27/97 20,400 $1.88 Open Market 05/10/00 4,103 $1.5000 Comp.for Dir.Svcs 09/02/97 6,500 $1.88 Open Market 01/10/02 8,000 $1.0625 Exercise Opts 09/03/97 3,100 $1.88 Open Market * Reverse split adjusted quantity
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer Mr. Tabin does not have any contracts, arrangements, understandings, or relationships (legal or otherwise) with any persons with respect to any securities of ART, including but not limited to transfer or voting of any securities of ART, finders fees; joint ventures; loan or option arrangements; puts or calls; guarantees of profits; divisions of profits or losses; or the giving or withholding of proxies. After reasonable inquiry and to the best knowledge and belief of each, the undersigned certify that the information set forth in this statement is true, complete and correct. Dated: November 22, 2002 /s/ Julius Tabin ---------------- Julius Tabin -----END PRIVACY-ENHANCED MESSAGE-----